Spravato®Registry-verifiedDesignated-centers model

Wojewódzki Szpital Psychiatryczny Im. Prof. Tadeusza Bilikiewicza W Gdańsku

Gdańsk, Poland

Treatment & access

Treatments offeredEsketamine nasal spray (Spravato®)
Access routeCovered by a national programme
Cost & coverage (registry status)Covered by NFZ (drug programme B.147)
ReimbursementNFZ drug programme B.147 - leczenie chorych na depresję lekooporną How reimbursement works in Europe →
Phone58 52 47 500
Websitehttps://wsp-bilikiewicz.pl/

Related listings

These records belong to the same organisation. They are listed separately because each is a distinct programme or location.

Another programme at this clinicWojewódzki Szpital Psychiatryczny Im. Prof. Tadeusza Bilikiewicza W Gdańsku : Spravato®

About this provider

This is a second NFZ-listed service point of the Provincial Psychiatric Hospital named after Prof. Tadeusz Bilikiewicz in Gdansk (ul. Srebrniki 17), the Pomeranian region's specialist psychiatric hospital, which per NFZ data holds a B.147 contract providing esketamine (Spravato) free of charge for treatment-resistant depression. Per its own site, the hospital runs six general psychiatry wards for adults with close to 300 beds, a day ward for adults, mental health outpatient clinics within a Mental Health Centre, a psychological-psychotherapeutic clinic, and child and adolescent services.

Services & programs

Six general psychiatry wards for adults (close to 300 beds)
Day ward for adults
Mental Health Clinic for Adults (within a Mental Health Centre, with outreach coordination and home visits)
Psychological-Psychotherapeutic Clinic
Psychiatric ward for children and adolescents
Mental health and psychological-psychotherapeutic clinics for children and adolescents
Day psychiatric rehabilitation ward for children and adolescents

Common questions

What is the route into the esketamine programme?

The B.147 programme requires a referral from a psychiatrist; the hospital's team then assesses eligibility, adults aged 18-75 with treatment-resistant depression, meaning non-response to at least two different antidepressants used adequately in the current episode.

How much does treatment cost?

The programme is fully funded by the NFZ: the medicine, supervised dosing at the hospital and monitoring visits are covered, for up to 34 weeks.

Looking at alternatives? One of the NFZ program B.147 centers, see all program centers in Poland in the directory and the Poland access guide.

1 more verified providers within 50 km

Rumia · 25 kmNiepubliczny Zakład Opieki Zdrowotnej Nr 1 Katarzyna Szalewska : Spravato®

See them on the provider map →

Verification

License / registryNFZ B.147
Official registryhttps://api.nfz.gov.pl/app-itl-api/queues?case=1&benefit=LECZENIE%20CHORYCH%20NA%20DEPRESJ%C4%98%20LEKOOPORN%C4%84&provider=Wojew%C3%B3dzki%20Szpital%20Psychiatryczny%20Im.%20Prof.%20Tadeusza%20Bilikiewicza%20W%20Gda%C5%84sku&format=json
Last verified2026-07-05

Re-checked every 90 days · how we verify and report corrections

Check your fit & enquire

Check my fit & enquire

Free 2-minute pre-screening in your browser · your summary goes only to Wojewódzki Szpital Psychiatryczny Im. Prof. Tadeusza Bilikiewicza W Gdańsku, with your consent.

What to prepare before you enquire

A referral or the contact details of your treating clinician
A list of medications you have tried (names, doses, duration)
A short diagnosis summary or discharge letters

Esketamine programmes usually require a documented history of antidepressant treatment.

Send documents directly to the provider when they reply. We never ask you to upload medical records.

Check my fit & enquire